intracellular glutathione reduction Glutathione-responsive nano-vehicles as a promising platform for targeted drug and gene delivery which makes it a powerful sulfur Glutathione: A Little Miracle for
Description
doi:10.1139/apnm-2014-0073 MedlinePlus
Foffani, G
Chien KS, Kim K, Nogueras-Gonzalez GM, Borthakur G , Naqvi K, Daver NG, Montalban-Bravo G, Cortes JE, DiNardo CD, Jabbour E, Alvarado Y, Andreeff M, Bose P, Jain N, Kadia TM, Huang X, Sheppard KB, Klingner-Winton C, Pierce SA, Dong XQ, Soltysiak KA, Kantarjian HM, Garcia-Manero G
However, the convenience of a single morning dose means most researchers prefer once-daily administration, and the clinical data supporting split dosing specifically for AOD 9604 is limited
I asked him if there was a middle option
doi: 10.1016/j.tins.2012.11.008
